Maribao, Arries Skyler Y.

HRN: 22-75-00  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/30/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/30/2025
10/09/2025
PO
300 Mg / 12 Ml
Q 8 Hours
Intestinal Amoebiasis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: